University of Minnesota

Abt Holding Company

Other

The United States of America As Represented by the Department of Health

The United States of America As Represented by the Secretary of Health

Healios K.k.

Mcl/llc

Leo T Furcht

Catherine M Verfaillie

Morayma Reyes

James B McCarthy

Amy P Skubitz

Effie C Tsilibary

Sharon M Wahl

Dennis L Polla

Ronald C McGlennen

Janice B Allen

Daniel L Mooradian

Gregg B Fields

Photini-Effie C Tsilibary

Aristidis S Charonis

Anja S Kohler

Jeffrey E Everett

Shobana Murali

Kevin L Billups

Martha M Wright

Anita Agarwal

Joseph F Tarsio

Angela Brienzo Frey

Dale S Gregerson

Mark Balles

Morayama Reyes

The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.

Pluripotent cells derived from bone marrow and methods for isolation

The present invention relates generally to mammalian multipotent adult stem cells (MASC), and more specifically to methods for obtaining, maintaining and differentiating MASC to cells of multiple tissue types. Uses of MASC in the therapeutic treatment of disease are also provided.

Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof

Multipotent adult stem cells and methods for isolation

The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells in cardiac indications.

Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure

Assay utilizing multipotent adult stem cells

Multipotent adult stem cells

Multiponent adult stem cells and methods for isolation

Peptides capable of modulating &#x3b2;1 integrin subunit dependent cell adhesion which includes a C-terminal aromatic amino acid residue and an amino acid residue having a lipophilic alkyl side chain as the penultimate C-terminal residue are provided. These 'LipAr' C-terminated peptides are typically capable of modulating the &#x3b2;1 integrin subunit dependent adhesion of cells, such as Ramos cells.

Peptides with &#x3b2;1 integrin subunit dependent cell adhesion modulating activity

A genetic testing system includes a miniaturized thermal cycling device and an integrated, unitary microchip based detection device with microfluidic controls, on chip electronics. The genetic testing system further uses dipped or coated polymeric materials on processed silicon as a means to facilitate amplification chemistry.

Integrated microchip genetic testing system

Growing community of inventors

Minneapolis, MN, United States of America

Leo T Furcht